You're Eating Enough Zinc. Your Genes May Be Stopping It.

SLC30A8 encodes a zinc transporter protein that sits on the surface of your cells and controls whether zinc from the bloodstream can actually enter the cell. Think of it as a lock on the cellular door. If the lock works normally, zinc flows into the cells that need it: your pancreatic beta cells (which need zinc for insulin function), your immune cells, your intestinal cells, your hair follicles. This transporter is working constantly to maintain the right zinc concentration inside the cell.

The R325W variant, carried by roughly 30% of the population, changes the structure of this transporter protein. The W allele version is less efficient at moving zinc across the cell membrane, meaning your cells have to work harder to maintain adequate zinc levels even when serum zinc looks normal. This variant was originally identified in the context of Type 2 diabetes because insulin-producing cells are particularly zinc-hungry, and when zinc can’t get in efficiently, insulin secretion suffers.

What this means for you day-to-day: You may have slow wound healing even after minor cuts or scrapes. Your immune system struggles to launch effective responses to infection, so you catch colds more easily and recover slowly. Your skin may be dull or slow to heal. Your hair may thin. You may notice white spots on your nails (a classic zinc deficiency sign). Your taste and smell may be duller than they should be.

TMPRSS6 encodes a protease that regulates hepcidin, a hormone that controls how much iron you absorb. But here’s what most people don’t realize: hepcidin also influences zinc absorption. Your gut uses the same transporters and absorption mechanisms for iron and zinc; they compete for the same pathways. TMPRSS6 is essentially the master regulator of how much of these minerals you pull from food.

The rs855791 variant, present in roughly 45% of the population, reduces TMPRSS6 function. This leads to higher hepcidin levels, which clamps down on both iron and zinc absorption, pushing your body into a mineral-conserving state. The original function of this variant was probably protective in ancestral populations with limited mineral availability, but in modern life with abundant food, it leaves you under-absorbing both minerals simultaneously.

What you experience: Fatigue that doesn’t fully respond to sleep or iron supplementation (because zinc is also low). Slow wound healing. Weak immunity with frequent infections. Brain fog and poor concentration. Thinning hair. Pale or pale-looking skin. You may feel chronically depleted of energy despite eating well.

HFE is famous for its role in iron overload (hemochromatosis), but the more common variants also affect how your body senses and regulates mineral status more broadly. HFE protein sits on intestinal cells and helps your body assess whether you have enough iron. When iron stores are adequate, HFE signals your gut to reduce absorption. When stores are low, it increases absorption. But HFE also influences the broader mineral-sensing system, including zinc regulation.

The H63D variant, carried by roughly 15-20% of people of European ancestry, reduces HFE function. This creates a kind of mineral-sensing confusion: your body struggles to accurately gauge your mineral stores, leading to dysregulation of both iron and zinc absorption. You may swing between periods of inadequate absorption and periods where you conserve minerals too aggressively.

What this feels like: Inconsistent energy levels. Good days and bad days with no clear pattern. Sometimes your supplements seem to work; other times they don’t. Hair that grows thin and breaks easily. Nails that are soft or peel. Skin texture issues. Immune system that’s unpredictably strong or weak.

The VDR gene encodes the vitamin D receptor, a protein that sits inside your cells and activates genes in response to active vitamin D (calcitriol). Vitamin D is crucial for regulating calcium absorption, but fewer people realize it’s also essential for zinc absorption and zinc-dependent immune function. When your VDR is working properly, adequate vitamin D levels tell your intestinal cells to make more zinc transporters. When VDR function is reduced, those zinc transporters don’t get made, even if your vitamin D levels look adequate.

The BsmI, FokI, and TaqI variants are common; combined, roughly 30-50% of the population carries at least one variant. People with these variants have reduced cellular responsiveness to vitamin D, meaning higher vitamin D levels are often needed to activate the gene expression necessary for optimal zinc absorption. You can be taking vitamin D, your levels can be in the normal range, and your cells still aren’t getting the message.

What this manifests as: Low energy and chronic fatigue that doesn’t fully improve with vitamin D supplementation. Slow healing of any kind: cuts, bruises, surgical wounds. Weak or unpredictable immune response. Muscle weakness or achiness. Brain fog. Poor bone health despite adequate calcium intake. Slow growth or development in children.

MTHFR encodes an enzyme crucial for converting folate into methylfolate, which your body uses not just for DNA synthesis and methylation, but also for regulating nutrient absorption and mineral transport. When MTHFR function is impaired, your methylation cycle slows. This doesn’t just affect folate and B12 status; it reduces your body’s ability to synthesize the proteins and cofactors needed for optimal mineral absorption and use, including zinc transporters.

The C677T variant is carried by roughly 40% of people with European ancestry. People with one or two copies have reduced MTHFR enzyme activity, which impairs folate conversion and weakens the methylation cycle, downstream reducing the efficiency of zinc transport systems. You may have adequate zinc intake, but your cells aren’t making the proteins needed to absorb and use it.

What this looks like: Fatigue that’s worse with B vitamin supplementation (a paradoxical response in people with severe MTHFR variants). Brain fog and difficulty concentrating. Slow wound healing. Weak immunity. Anxiety or mood changes. Poor response to standard zinc supplementation. You may have been told you have a methylation problem, but you didn’t realize it affects mineral absorption too.

COMT encodes catechol-O-methyltransferase, an enzyme that breaks down dopamine, norepinephrine, and epinephrine. People often associate COMT only with stress and neurotransmitter metabolism, but COMT also plays a role in methylation-dependent processes throughout the body, including the regulation of nutrient transporters. When COMT function is altered, your methylation status becomes dysregulated, which can impair the expression and function of zinc transporters and other absorption-related proteins.

COMT variants include the fast-metabolizer (Val158Met GG genotype) and slow-metabolizer (AA) types, plus heterozygotes. Slow COMT metabolizers accumulate catecholamines under stress and have reduced methylation capacity, which downstream reduces the expression of zinc transport proteins. Fast metabolizers have the opposite problem: they clear catecholamines too quickly and may be underdrive their transport systems, also leading to zinc dysregulation.

What this presents as: Energy crashes and mood swings, particularly when stressed. Slow recovery from stress. Brain fog that worsens with stimulants (caffeine makes zinc dysregulation worse because of the catecholamine surge). Anxiety. Poor wound healing and weak immunity during stressful periods. Some people find that their zinc status fluctuates with life stress, because COMT variants mean stress hormones directly affect mineral transport.